Kestra Medical Technologies, Ltd.
KMTS · Price history
Price at last available close
$29.87
+$1.41 (+4.95%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Kestra Medical Technologies, Ltd.
Primary reporting period: 2026-04-30 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes.
How they make money
Kestra Medical Technologies generates revenue primarily through the commercialization of its wearable cardiac monitoring and therapeutic devices. The company utilizes a business model that involves the deployment of its Cardiac Recovery System platform, supported by recurring service revenue from remote patient monitoring, data analytics, and clinical support services provided to healthcare providers.
Products & services
The company offers the ASSURE Wearable Cardioverter Defibrillator (WCD) system, complemented by the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services.
Brands & revenue mix
The primary brand for the company's wearable cardioverter defibrillator and associated patient application.
Separate brand revenue is not available in this research.Source
Remote patient data platform brand.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer types
- Healthcare providersSource
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
- Medical technology suppliers — The company collaborates with experienced, top-tier medical technology suppliers to support its scalable supply chain and device manufacturing.Source
Strengths
Financial risk observations and what to check
These are saved observations about business performance, not predictions. Review the company filings alongside the interpretation below. Latest stored financial period end: 2026-07-31.
Total debt increased 71.4% versus the same quarter last year.
Compare the added borrowing with available cash, cash generation and maturities. A percentage increase from a small starting balance can look large without measuring the full debt burden.
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
29
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
49
Weak
Financial Strength
31
Business Quality / Moat
83
Management
40
Growth Quality
64
Risk / Durability
14
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
32
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
45/100
Building Historical Record
Model Score 45/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
No strong positive signal is being highlighted from the currently available summary data.
- •Debt service risk
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for KMTS
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can KMTS maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •How long can KMTS fund negative free cash flow using its current cash position before it may need more debt or new shares?
- •Does KMTS's balance between cash and debt leave enough flexibility if business conditions weaken?
- •What specifically needs to improve for KMTS to reach sustainable profitability?
- •What future growth or profitability would be needed to justify KMTS's current valuation?
Essential Investment Snapshot
Wall Street Score
29
Opportunity Score
32
Market Cap
$1.78B
P/E Ratio
-10.2
EPS
$-2.67
52-Week High
$30.00
52-Week Low
$17.34
Beta
0.62
Analyst Target
$30.00
Shares Outstanding
58.4M
Total Revenue
$106.7M
Total Debt
$76.4M
Dividend
No current dividend
Liquidation Value / Share
$3.81
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Strong upward momentum
Elevated movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for KMTS
Detected from reported data — verify before acting.Debt service risk
Interest coverage is low (~-17.9x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total callsNo personal call yet on KMTS.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Innovative wearable cardiovascular disease management technology.
- +Scalable supply chain and digital healthcare integration.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Instruments & Supplies industry.
- −Dependence on third-party suppliers for device components.
- −Market adoption and regulatory risks in the medical device industry.
- −Negative free cash flow may increase the need for outside financing and dilution.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
2 historical score records availablePrevious Score
29
Jul 24, 2026
Change
-0.3
points
Current Score
29
Oct 1, 2026
Category Changes
KMTS decreased 0.3 points because Asset declined by 3.5 points, Moat declined by 13.5 points.
Positive Contributors
- + Revenue improved by 12.1 points
Negative Contributors
- − Asset declined by 3.5 points
- − Moat declined by 13.5 points
Projected Score
Projected Score
32
Projected Change
+2.4 points
Preliminary comparable-period financial changes suggest improvement of approximately 2.4 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Valuation unavailableCurrent Price
$29.87
Model Intrinsic Value
—
Difference
—
Margin of Safety
—
Intrinsic value is not currently available for this stock, so valuation can't be calculated.
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Large reported revenue change: +59.0%
Revenue changed sharply from 2025 to 2026. This can reflect a real business change, acquisition, divestiture, discontinued operations, restatement, or reporting-basis change. Compare the underlying filing before treating it as normal growth or decline.
TTM may combine quarters from before and after the event, so its trend can also be distorted.
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2026 | 2025 | 2024 | 2023 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $106.7M | $95.1M | $59.8M | $27.8M | ···· | ···· | ···· |
| Cost of Revenue | $49.2M | $46.3M | $35.6M | $27.5M | ···· | ···· | ···· |
| Gross Profit | $57.5M | $48.9M | $24.2M | $362K | ···· | ···· | ···· |
| Research & Development | $22.3M | $19.5M | $15.7M | $15.5M | ···· | ···· | ···· |
| SG&A Expenses | $178.8M | $164.1M | $114.9M | $69.9M | ···· | ···· | ···· |
| Operating Expenses | $201.0M | $183.6M | $130.6M | $85.4M | ···· | ···· | ···· |
| EBITDA | -$163.2M | -$150.0M | -$98.0M | -$76.3M | ···· | ···· | ···· |
| Operating Income | -$143.5M | -$134.7M | -$106.4M | -$85.1M | ···· | ···· | ···· |
| Interest Expense | $7.6M | $7.5M | $7.7M | $6.2M | ···· | ···· | ···· |
| Income Before Tax | -$149.6M | -$131.3M | -$113.7M | -$94.1M | ···· | ···· | ···· |
| Income Tax Expense | $311K | $294K | $135K | $24K | ···· | ···· | ···· |
| Net Income | -$149.9M | -$131.6M | -$113.8M | -$94.1M | ···· | ···· | ···· |
| Basic EPS | $-2.68 | $-2.43 | $-5.13 | $-2.04 | ···· | ···· | ···· |
| Basic Shares | 58.57M | 58.40M | 49.53M | 49.53M | ···· | ···· | ···· |
| Diluted Shares | 58.57M | 58.40M | 49.53M | 49.53M | ···· | ···· | ···· |
Earnings Summary
Revenue
$31.0M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
-$0.75
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
+71.4%
Cash Change
-65.9%
Margin Change
-9.0 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Weakened
- Margins contracted
- Cash position declined
- Debt increased
Potential Score Impact
Positive indicators included revenue growth, EPS growth. Pressure indicators included cash levels, debt levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 59.9%. EPS increased 50.0%. Cash declined 65.9%. Total debt increased 71.4%. Net income margin declined by 9.0 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
2 historical records2 historical score records available.
Historical Score Chart
2 of 2 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Instruments & SuppliesNews
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Up – Should You Buy?
Kestra Medical Technologies Earns Five-Star Rating on Newsweek's List of America's Greatest Mid-Market Companies
Kestra Medical: Strong Scaling Story, But Profitability Still On The Horizon
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down After Earnings Miss
Rumor Mill · KMTS
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial